Yi Tan

Prof. Yi Tan


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2020 in Nature Reviews Cardiology
Verified
Journal Article
Closed access
PDF file
Yi TanYi Tan
Yi Tan
ZZZhiguo Zhang
Zhiguo Zhang
CZChao Zheng
Chao Zheng
KWKupper A. Wintergerst
Kupper A. Wintergerst
Bradley B. KellerBradley B. Keller
Bradley B. Keller
Lu CaiLu Cai
Lu Cai

1 February 2020 in Trends in Molecular Medicine
Verified
Journal Article
Open access
XDXiaozhen Dai
Xiaozhen Dai
XYXiaoqing Yan
Xiaoqing Yan
KWKupper A. Wintergerst
Kupper A. Wintergerst
LCLu Cai
Lu Cai
Bradley B. KellerBradley B. Keller
Bradley B. Keller
Yi TanYi Tan
Yi Tan
Nuclear factor erythroid 2-related factor 2 (Nrf2) is ubiquitously expressed in most eukaryotic cells and functions to induce a broad range of cellular defenses against exogenous and endogenous stresses, including oxidants, xenobiotics, and excessive nutrient/metabolite supply. Because the production and fate of stem cells are often modulated by cellular redox and metabolic homeostasis, important roles of Nrf2 have emerged in the regulation of stem cell quiescence, survival, self-renewal, proliferation, senescence, and differentiation. In a rapidly advancing field, this review summarizes Nrf2 signaling in the context of stem cell state and function and provides a rationale for Nrf2 as a therapeutic target in stem cell-based regenerative medicine.

1 May 2018 in Redox Biology
Verified
Journal Article
Open access
YXYing Xin
Ying Xin
YBYang Bai
Yang Bai
XJXin Jiang
Xin Jiang
SZShanshan Zhou
Shanshan Zhou
YWYuehui Wang
Yuehui Wang
LCLu Cai
Lu Cai
Activation of nuclear factor erythroid 2-related factor 2 (Nrf2) by sulforaphane (SFN) protects from, and deletion of the Nrf2 gene exaggerates, diabetic cardiomyopathy. Angiotensin II (Ang II) plays a critical role in the development of diabetic cardiomyopathy. Therefore, whether SFN prevents Ang II-induced cardiomyopathy through activation of Nrf2 was examined using wild-type, global deletion of Nrf2 gene (Nrf2-KO) and cardiomyocyte-specific overexpression of Nrf2 gene (Nrf2-TG) mice. Administration of a subpressor dose of Ang II to wild-type mice induced cardiac oxidative stress, inflammation, remodeling and dysfunction, all of which could be prevented by SFN treatment with Nrf2 up-regulation and activation. Nrf2-KO mice are susceptible, and Nrf2-TG mice are resistant, respectively, to Ang II-induced cardiomyopathy. Meanwhile, the ability of SFN to protect against Ang II-induced cardiac damage was lost in Nrf2-KO mice. Up-regulation and activation of Nrf2 by SFN is accompanied by activation of Akt, inhibition of glycogen synthase kinase (GSK)-3β, and accumulation of Fyn in nuclei. In vitro up-regulation of Nrf2 by SFN was abolished and nuclear Fyn accumulation was increased when cardiac cells were exposed to a PI3K inhibitor or GSK-3β-specific activator. These results suggest that Nrf2 plays a central role in the prevention of Ang II-induced cardiomyopathy, and SFN prevents Ang II-induced cardiomyopathy partially via the Akt/GSK-3β/Fyn-mediated Nrf2 activation.

30 January 2017 in Circulation Research
Verified
Journal Article
Closed access
PDF file
XDXiaozhen Dai
Xiaozhen Dai
XYXiaoqing Yan
Xiaoqing Yan
JZJun Zeng
Jun Zeng
JCJing Chen
Jing Chen
YWYuehui Wang
Yuehui Wang
Yi TanYi Tan
Yi Tan
Rationale:: Endothelial progenitor cells (EPCs) respond to stromal cell–derived factor 1 (SDF-1) through chemokine receptors CXCR7 and CXCR4. Whether SDF-1 receptors involves in diabetes mellitus–induced EPCs dysfunction remains unknown. Objective:: To determine the role of SDF-1 receptors in diabetic EPCs dysfunction. Methods and Results:: CXCR7 expression, but not CXCR4 was reduced in EPCs from db/db mice, which coincided with impaired tube formation. Knockdown of CXCR7 impaired tube formation of EPCs from normal mice, whereas upregulation of CXCR7 rescued angiogenic function of EPCs from db/db mice. In normal EPCs treated with oxidized low-density lipoprotein or high glucose also reduced CXCR7 expression, impaired tube formation, and increased oxidative stress and apoptosis. The damaging effects of oxidized low-density lipoprotein or high glucose were markedly reduced by SDF-1 pretreatment in EPCs transduced with CXCR7 lentivirus but not in EPCs transduced with control lentivirus. Most importantly, EPCs transduced with CXCR7 lentivirus were superior to EPCs transduced with control lentivirus for therapy of ischemic limbs in db/db mice. Mechanistic studies demonstrated that oxidized low-density lipoprotein or high glucose inhibited protein kinase B and glycogen synthase kinase-3β phosphorylation, nuclear export of Fyn and nuclear localization of nuclear factor (erythroid-derived 2)-like 2 (Nrf2), blunting Nrf2 downstream target genes heme oxygenase-1, NAD(P)H dehydrogenase (quinone 1) and catalase, and inducing an increase in EPC oxidative stress. This destructive cascade was blocked by SDF-1 treatment in EPCs transduced with CXCR7 lentivirus. Furthermore, inhibition of phosphatidylinositol 3-kinase/protein kinase B prevented SDF-1/CXCR7-mediated Nrf2 activation and blocked angiogenic repair. Moreover, Nrf2 knockdown almost completely abolished the protective effects of SDF-1/CXCR7 on EPC function in vitro and in vivo. Conclusions:: Elevated expression of CXCR7 enhances EPC resistance to diabetes mellitus–induced oxidative damage and improves therapeutic efficacy of EPCs in treating diabetic limb ischemia. The benefits of CXCR7 are mediated predominantly by a protein kinase B/glycogen synthase kinase-3β/Fyn pathway via increased activity of Nrf2.

4 June 2015 in Diabetologia
Verified
Journal Article
Closed access
PDF file
CZChi Zhang
Chi Zhang
ZHZhifeng Huang
Zhifeng Huang
JGJunlian Gu
Junlian Gu
XYXiaoqing Yan
Xiaoqing Yan
XLXuemian Lu
Xuemian Lu
XLXiaokun Li
Xiaokun Li

30 May 2011 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
XDXiaozhen Dai
Xiaozhen Dai
Yi TanYi Tan
Yi Tan
SCShaoxi Cai
Shaoxi Cai
XXXin Xiong
Xin Xiong
LWLingqiao Wang
Lingqiao Wang
LCLu Cai
Lu Cai
Previous studies confirmed that stromal cell‐derived factor 1 (SDF‐1) was a principal regulator of retention, migration and mobilization of haematopoietic stem cells and endothelial progenitor cells (EPCs) during steady‐state homeostasis and injury. CXC chemokine receptor 4 (CXCR4) has been considered as the unique receptor of SDF‐1 and as the only mediator of SDF‐1‐induced biological effects for many years. However, recent studies found that SDF‐1 could bind to not only CXCR4 but also CXC chemokine receptor 7 (CXCR7). The evidence that SDF‐1 binds to the CXCR7 raises a concern how to distinguish the potential contribution of the SDF‐1/CXCR7 pathway from SDF‐1/CXCR4 pathway in all the processes that were previously attributed to SDF‐1/CXCR4. In this study, the role of CXCR7 in EPCs was investigated in vitro. RT‐PCR, Western blot and flow cytometry assay demonstrate that both CXCR4 and CXCR7 were expressed highly in EPCs. The adhesion of EPCs induced by SDF‐1 was inhibited by blocking either CXCR4 or CXCR7 with their antibodies or antagonists. SDF‐1 regulated the migration of EPCs via CXCR4 but not CXCR7. However, the transendothelial migration of EPCs was inhibited by either blocking of CXCR4 or CXCR7. Both CXCR7 and CXCR4 are essential for the tube formation of EPCs induced by SDF‐1. These results suggested that both CXCR7 and CXCR4 are important for EPCs in response to SDF‐1, indicating that CXCR7 may be another potential target molecule for angiogenesis‐dependent diseases.